This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

€500 savings end in:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
THE SPRINGTIME PARTNERING EVENT
March 18–20, 2024 | Barcelona, SpainMarch 26–27, 2024 | Digital Partnering

Lovaltech

Profile

Lovaltech is dedicated to the development of nasal vaccines that trigger the mucosal compartment of the immune system and immediately block the transmission of the infectious agent in addition to activating the classical humoral and cellular immune system. The company was launched in 2022 as a spin-off from the University of Tours (France) and has been awarded the France 2030 Deeptech label in recognition of its excellence in pioneering a radically new approach to vaccination.